Show simple item record

Comparison of "selective" opiate receptor antagonists on the isolated mouse vas deferens

dc.contributor.authorSmith, Charles B.en_US
dc.contributor.authorBennett-Kelly, L.en_US
dc.contributor.authorWoods, James H.en_US
dc.date.accessioned2006-04-07T18:16:28Z
dc.date.available2006-04-07T18:16:28Z
dc.date.issued1984-12en_US
dc.identifier.citationSmith, C. B., Bennett-Kelly, L., Woods, J. H. (1984/12)."Comparison of "selective" opiate receptor antagonists on the isolated mouse vas deferens." Neuropeptides 5(1-3): 161-164. <http://hdl.handle.net/2027.42/24610>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6WNR-4C48C8T-8X/2/562dd126bad8f8e9524a81bc0e8eaa2fen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/24610
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6099488&dopt=citationen_US
dc.description.abstractThe selectivity and relative potencics of opiate receptor antagonists were compared on the mouse vas deferens preparation. ICI-174864 was found to be a highly selective antagonist at delta opiate receptors equal in potency to naltrexone in blocking the actions of delta agonists. Although less potent than naltrexone, beta-funal trexamine (beta-FNA) and Mr-1452, like naltrexone, were less selective in that they blocked the actions of mu, delta and kappa agonists. The relative potencies of beta-FNA and Mr-1452 in antagonizing the three types of agonists also were similar to naltrexone.en_US
dc.format.extent291023 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleComparison of "selective" opiate receptor antagonists on the isolated mouse vas deferensen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelChemical Engineeringen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelEngineeringen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, The University of Michigan Medical School, Ann Arbor, MI 48109, USAen_US
dc.contributor.affiliationumDepartment of Pharmacology, The University of Michigan Medical School, Ann Arbor, MI 48109, USAen_US
dc.contributor.affiliationumDepartment of Pharmacology, The University of Michigan Medical School, Ann Arbor, MI 48109, USAen_US
dc.identifier.pmid6099488en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/24610/1/0000020.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0143-4179(84)90052-0en_US
dc.identifier.sourceNeuropeptidesen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.